...
首页> 外文期刊>American Journal of Clinical Oncology: Cancer Clinical Trials >Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
【24h】

Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation

机译:基于膀胱切除术治疗肌肉侵袭性膀胱癌患者结果的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Radical cystectomy currently remains the standard of care for muscle-invasive bladder cancer. However, surgery can be associated with considerable morbidity and mortality, including the removal of the bladder. An alternative strategy is to preserve the bladder through concurrent chemoradiation following a maximal transurethral resection of the tumor. National protocols using a bladder-preservation approach have demonstrated disease-specific outcomes comparable to radical cystectomy in selected patients, but these results have not been replicated in previously reported population-based series. Here, we describe an outcomes analysis of patients with muscle-invasive bladder cancer treated with either radical surgery or bladder-preserving chemoradiation (BPCRT) for those patients meeting BPCRT criterion using the National Cancer Database (NCDB). Materials and Methods: Using the NCDB, patients with American Joint Commission on Cancer clinical T2-3, N0, M0 urothelial carcinoma diagnosed between 2004 and 2013 were included for analysis. Only patients treated with definitive intent with either radical cystectomy or concurrent chemotherapy and radiation after a maximal transurethral tumor resection were included. Propensity-score matching was used. Results: Among 8454 eligible patients, 7276 (86%) underwent radical cystectomy, and 1178 (14%) underwent BPCRT. Patients undergoing BPCRT were significantly older (median age, 77 vs. 68 y; P0.001) and had higher Charlson-Deyo comorbidity scores (P=0.002). Using propensity-matched analysis, 1002 patients remained in each cohort, and there was no significant difference in survival found between the 2 cohorts (median overall survival, 2.7 vs. 3.0 y [P=0.20]; 4-year overall survival, 39.1% and 42.6% [P=0.15], for BPCRT and surgery, respectively). In addition, the hazard ratio (HR) of surgery versus BPCRT decreased over time, with an initial HR of 1.27 favoring BPCRT which decreased by a factor of 0.85 per year. Conclusions: From 2004 to 2013, similar to 14% of patients from the NCDB who potentially met bladder-preservation criteria underwent the procedure. Our propensity-matched analysis is the only report of its kind to demonstrate similar survival outcomes with bladder preservation when patients are properly selected. This study is also the first to demonstrate a dynamic HR between radical surgery and BPCRT over time.
机译:目的:自由基膀胱切除术目前仍然是肌肉侵袭性膀胱癌的护理标准。然而,手术可以与相当大的发病率和死亡率相关,包括去除膀胱。替代策略是通过在肿瘤的最大经尿道切除后通过同时进行化学地进行膀胱。使用膀胱保存方法的国家方案表明,在选定患者中具有与自由基膀胱切除术相当的疾病特异性结果,但这些结果尚未在先前报告的基于人口的系列中复制。在这里,我们描述了使用国家癌症数据库(NCDB)符合BPCRT标准的那些患者治疗肌肉侵袭性膀胱癌患者的患者的结果分析。材料和方法:使用NCDB,美国联合癌症临床T2-3,N0,M0诊断为2004年至2013年诊断的患者患者进行分析。仅包括在最明显的膀胱切除术或同时化疗和辐射后患有明确的患者,并在最大的经尿道瘤切除后才有。使用倾向分数匹配。结果:在8454名符合条件的患者中,7276(86%)接受自由基膀胱切除术,1178(14%)接受了BPCRT。接受BPCR的患者显着较为较大(中位年龄,77 vs.68 y; P <0.001),并且具有更高的Charlson-Deyo合并症分数(P = 0.002)。使用倾向匹配的分析,每队持续1002名患者,2个队列(中位整体存活率,2.7对3.0 Y [P = 0.20]; 4年整体生存,39.1%和42.6%[p = 0.15],分别用于BPCRT和手术)。此外,手术的危害比(HR)随着时间的推移而降低,初始HR为1.27,最有利于BPCRT,每年减少0.85倍。结论:从2004年到2013年,类似于来自NCDB的14%的患者,潜在达到膀胱保存标准的过程介绍了该程序。我们的倾向匹配的分析是患者正确选择患者时似乎展示了膀胱保存的类似存活结果的唯一报告。本研究也是第一个在随着时间的推移中展示激进手术和BPCR之间的动态HR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号